We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+15.94%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.73B
AUM Growth
+$152M
Cap. Flow
-$38.6M
Cap. Flow %
-2.23%
Top 10 Hldgs %
25.39%
Holding
270
New
10
Increased
28
Reduced
188
Closed
10

Top Buys

Rank Stock Value
1
ESTA icon
Establishment Labs
ESTA
+$11.2M
2
PBH icon
Prestige Consumer Healthcare
PBH
+$6.68M
3
VRNA
Verona Pharma
VRNA
+$6.54M
4
ADUS icon
Addus HomeCare
ADUS
+$3.51M
5
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$2.65M

Top Sells

Rank Stock Value
1
BBBY
Bed Bath & Beyond
BBBY
+$11.2M
2
LRN icon
Stride
LRN
+$9.83M
3
NXGN
NextGen Healthcare, Inc. Common Stock
NXGN
+$9.14M
4
AX icon
Axos Financial
AX
+$5.93M
5
DEN
Denbury Inc.
DEN
+$3.51M

Sector Composition

Rank Sector Weight
1 Healthcare 30.1%
2 Technology 23.78%
3 Industrials 19.76%
4 Consumer Discretionary 6.36%
5 Communication Services 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NBIX icon
26
Neurocrine Biosciences
NBIX
$16.6B
$17.3M 1%
131,621
-592
-0.4% -$68.1K
POOL icon
27
Pool Corp
POOL
$7.5B
$17.1M 0.99%
42,949
-356
-0.8% -$125K
SSTK icon
28
Shutterstock
SSTK
$219M
$16.9M 0.98%
350,492
-7,147
-2% -$302K
OABI icon
29
OmniAb
OABI
$447M
$16.7M 0.97%
2,712,644
-68,182
-2% -$335K
MMS icon
30
Maximus
MMS
$3.1B
$16.6M 0.96%
198,274
+508
+0.3% +$40.5K
KRTX
31
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$15.9M 0.92%
50,171
+10,790
+27% +$2.1M
LCII icon
32
LCI Industries
LCII
$2.65B
$15.8M 0.91%
125,445
-26,214
-17% -$3.02M
EB
33
DELISTED
Eventbrite
EB
$15.5M 0.9%
1,853,713
+230,288
+14% +$1.86M
SUPN icon
34
Supernus Pharmaceuticals
SUPN
$2.77B
$15.3M 0.89%
529,952
-14,516
-3% -$385K
RDWR icon
35
Radware
RDWR
$1.19B
$15.2M 0.88%
913,993
-37,814
-4% -$600K
FOLD
36
DELISTED
Amicus Therapeutics
FOLD
$15.1M 0.88%
1,065,965
-12,900
-1% -$146K
MTN icon
37
Vail Resorts
MTN
$5.3B
$14.7M 0.85%
68,919
-684
-1% -$150K
IOVA icon
38
Iovance Biotherapeutics
IOVA
$2.87B
$14.2M 0.82%
1,750,907
+28,196
+2% +$148K
RBA icon
39
RB Global
RBA
$17.5B
$13.4M 0.78%
201,061
-1,030
-0.5% -$66.2K
WIX icon
40
WIX.com
WIX
$2.52B
$13.4M 0.78%
108,975
-468
-0.4% -$45.2K
LMAT icon
41
LeMaitre Vascular
LMAT
$1.86B
$13.2M 0.76%
232,237
-15,481
-6% -$811K
BCRX icon
42
BioCryst Pharmaceuticals
BCRX
$2.4B
$13.2M 0.76%
2,197,261
-78,377
-3% -$454K
APPS icon
43
Digital Turbine
APPS
$1.74B
$11.9M 0.69%
1,731,011
-83,916
-5% -$468K
KNSA icon
44
Kiniksa Pharmaceuticals
KNSA
$5.93B
$11.2M 0.65%
636,029
-14,337
-2% -$236K
CEVA icon
45
CEVA Inc
CEVA
$1.08B
$10.4M 0.6%
457,128
-10,643
-2% -$219K
TRAK icon
46
ReposiTrak
TRAK
$159M
$10.2M 0.59%
1,016,408
-78,025
-7% -$765K
EOLS icon
47
Evolus
EOLS
$501M
$9.54M 0.55%
906,195
-198,964
-18% -$1.78M
PRO
48
DELISTED
PROS Holdings
PRO
$9.46M 0.55%
243,983
-7,131
-3% -$256K
VRNA
49
DELISTED
Verona Pharma
VRNA
$9.32M 0.54%
468,929
+443,055
+1,712% +$6.54M
ASPN icon
50
Aspen Aerogels
ASPN
$518M
$9.16M 0.53%
580,491
-42,644
-7% -$440K
1
2
3 4 5

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q4 2023 Portfolio in Review

As of Q4 2023, Rice Hall James & Associates held 270 positions worth $1.73B, up 9.7% from $1.57B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates's Q4 2023 filing shows 10 new, 28 increased, 188 reduced and 10 closed positions. Its largest new stake was Addus HomeCare: 40,418 shares worth $3.75M. The largest sale was Bed Bath & Beyond, an estimated $11.2M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q4 2023 buy was Addus HomeCare: 40,418 shares worth $3.75M.
  • Rice Hall James & Associates added most to Establishment Labs in Q4 2023, an estimated $11.2M increase.
  • Rice Hall James & Associates's biggest Q4 2023 reduction was Bed Bath & Beyond, cutting an estimated $11.2M.
  • Rice Hall James & Associates fully exited NextGen Healthcare, Inc. Common Stock in Q4 2023, selling an estimated $9.14M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $1.73B portfolio in Q4 2023.
  • Rice Hall James & Associates opened 10 new positions and closed 10 in Q4 2023.
  • Rice Hall James & Associates's portfolio value rose 9.7% quarter-over-quarter to $1.73B.

Based on Rice Hall James & Associates's 13F filing for Q4 2023, filed 9 Feb 2024.